Clinical Trial Registry
Banner

Invest in Hemostemix and be a part of the Future of Stem Cell Therapy 

We are dedicated to advancing the science of ACP-01 and creating opportunities to change the therapeutic landscape.

Interested in hearing about news and events?  Subscribe Here

 

2025 Annual General Meeting Materials

Investor Presentation Q4 2025 

SEDAR Proxy

NI Card

Financials

Notice Information Circular

2024 Annual General Meeting Materials

Financials

2023 Annual General Meeting Materials

2022 Annual General Meeting Materials

Comp-1

The Addressable Market - what issues the patients face

The global CLTI market was valued at $4.02Billion in 2022. The Ischemic Heart Disease (IHD)drugs market reached US $6.1 Billion in 2022

final-1
final-3
final-4